Exact Mass: 339.0412708
Exact Mass Matches: 339.0412708
Found 148 metabolites which its exact mass value is equals to given mass value 339.0412708,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid
C9H14N3O9P (339.04676440000003)
5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid, also known as 1-(5-phosphoribosyl)-4-carboxy-5-aminoimidazole or 1-(5-phospho-D-ribosyl)-5-amino-4-imidazolecarboxylic acid, belongs to the class of organic compounds known as pentose phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups. 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid is a very strong basic compound (based on its pKa). 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid exists in all living species, ranging from bacteria to humans. Within humans, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid participates in a number of enzymatic reactions. In particular, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid can be converted into 5-aminoimidazole ribonucleotide; which is mediated by the enzyme multifunctional protein ADE2. In addition, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid and L-aspartic acid can be converted into SAICAR; which is mediated by the enzyme multifunctional protein ADE2. In humans, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid is involved in the metabolic disorder called Lesch-Nyhan syndrome (LNS). Outside of the human body, 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid has been detected, but not quantified in, several different foods, such as ohelo berries, Chinese mustards, peach (var.), jackfruits, and saskatoon berries. This could make 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid a potential biomarker for the consumption of these foods. 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid is an intermediate in purine metabolism. 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid is converted from aminoimidazole ribotide via phosphoribosylaminoimidazole carboxylase (EC: 4.1.1.21). 5-amino-1-(5-phospho-D-ribosyl) imidazole-4-carboxylate is an intermediate in purine metabolism. 5-amino-1-(5-phospho-D-ribosyl) imidazole-4-carboxylate is converted from aminoimidazole ribotide via phosphoribosylaminoimidazole carboxylase [EC: 4.1.1.21]. [HMDB]. 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate is found in many foods, some of which are red raspberry, rapini, alpine sweetvetch, and european chestnut. COVID info from COVID-19 Disease Map D007004 - Hypoglycemic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N5-Carboxyaminoimidazole ribonucleotide
C9H14N3O9P (339.04676440000003)
N5-Carboxyaminoimidazole ribonucleotide is an intermediate in purine nucleotides de novo biosynthesis. Purine nucleotides participate in many aspects of cellular metabolism including the structure of DNA and RNA, serving as enzyme cofactors, functioning in cellular signaling, acting as phosphate group donors, and generating cellular energy. Maintenance of the proper balance of intracellular pools of these nucleotides is critical to normal function. This occurs through a combination of de novo biosynthesis and salvage pathways for pre-existing purine bases, nucleosides and nucleotides. The de novo biosynthetic pathway for purine nucleotides is highly conserved among organisms, but its regulation and the organization of the genes encoding the enzymes vary. The fourteen step pathway contains ten steps that branch at inosine-5-phosphate to form adenosine-5-phosphate and guanosine-5-phosphate, each in two steps. [HMDB] N5-Carboxyaminoimidazole ribonucleotide is an intermediate in purine nucleotides de novo biosynthesis. Purine nucleotides participate in many aspects of cellular metabolism including the structure of DNA and RNA, serving as enzyme cofactors, functioning in cellular signaling, acting as phosphate group donors, and generating cellular energy. Maintenance of the proper balance of intracellular pools of these nucleotides is critical to normal function. This occurs through a combination of de novo biosynthesis and salvage pathways for pre-existing purine bases, nucleosides and nucleotides. The de novo biosynthetic pathway for purine nucleotides is highly conserved among organisms, but its regulation and the organization of the genes encoding the enzymes vary. The fourteen step pathway contains ten steps that branch at inosine-5-phosphate to form adenosine-5-phosphate and guanosine-5-phosphate, each in two steps.
1-(4-Hydroxy-2-methylpyrimidin-5-ylmethyl)-3-(2-hydroxyethyl)-2-methylpyridinium bromide
Cefacetrile
C13H13N3O6S (339.05250380000007)
Cefacetrile is only found in individuals that have used or taken this drug. It is a derivative of 7-aminocephalosporanic acid.In vitro tests demonstrate that the bactericidal action of cephalosporins results from inhibition of cell wall synthesis. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
5-Phosphoribosyl-4-carboxy-5-aminoimidazole
C9H14N3O9P (339.04676440000003)
5-Phosphoribosyl-4-carboxy-5-aminoimidazole is also known as AICA Ribonucleotide, (D-ribofuranosyl)-isomer or AICAR. 5-Phosphoribosyl-4-carboxy-5-aminoimidazole is considered to be slightly soluble (in water) and acidic D007004 - Hypoglycemic Agents
Glutathione thiol
Mesotrione
CONFIDENCE standard compound; EAWAG_UCHEM_ID 258 CONFIDENCE standard compound; INTERNAL_ID 3180
2,6-dimethyl-4-[2-(trifluoromethyl)phenyl]pyridine-3,5-dicarboxylic acid
2-Hydroxy-1,9-dimethoxy-4-oxo-4,5-dihydrodibenzo[cd,f]indole-3-carboxylic acid
2-chloro-4-fluoro-N-[(E)-2-phenylethenyl]sulfonylbenzamide
CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4425; ORIGINAL_PRECURSOR_SCAN_NO 4423 DATASET 20200303_ENTACT_RP_MIX506; CONFIDENCE standard compound; INTERNAL_ID 736; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4425; ORIGINAL_PRECURSOR_SCAN_NO 4423 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4443; ORIGINAL_PRECURSOR_SCAN_NO 4441 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4400; ORIGINAL_PRECURSOR_SCAN_NO 4398 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4433; ORIGINAL_PRECURSOR_SCAN_NO 4430 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4427; ORIGINAL_PRECURSOR_SCAN_NO 4424 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4415; ORIGINAL_PRECURSOR_SCAN_NO 4412 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8686; ORIGINAL_PRECURSOR_SCAN_NO 8681 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8733; ORIGINAL_PRECURSOR_SCAN_NO 8729 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8742; ORIGINAL_PRECURSOR_SCAN_NO 8739 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8783; ORIGINAL_PRECURSOR_SCAN_NO 8781 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8789; ORIGINAL_PRECURSOR_SCAN_NO 8786 CONFIDENCE standard compound; INTERNAL_ID 736; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8797; ORIGINAL_PRECURSOR_SCAN_NO 8795
Phosphoribosyl carboxyaminoimidazole
C9H14N3O9P (339.04676440000003)
N5-carboxyaminoimidazole ribonucleotide
C9H14N3O9P (339.04676440000003)
Cefacetrile
C13H13N3O6S (339.05250380000007)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
3-[[2-(3,4-dichlorophenoxy)acetyl]amino]benzoic acid
C15H11Cl2NO4 (339.00651060000007)
2-DIMETHYLAMINOMETHYL-4-(2-AMINOMETHYLTHIOMETHYL)THIAZOLE TRIHYDROCHLORIDE
C9H20Cl3N3S2 (339.01641700000005)
1-(4-PHENYL-THIAZOL-2-YL)-5-TRIFLUOROMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID
C14H8F3N3O2S (339.02893040000004)
3-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-4-(3-nitrophenyl)-3-buten-2-one
5-BROMO-1H-T-BUTOXYCARBONYL-INDOLE-3-CARBOXYLIC ACID
C14H14BrNO4 (339.01061440000007)
2-[(4-chlorophenyl)sulfonylamino]-3-phenylpropanoic acid
C15H14ClNO4S (339.03320340000005)
N-Benzyl-3-bromo-5-methylbenzenesulfonamide
C14H14BrNO2S (338.99285640000005)
2-[N-(P-CHLOROPHENYL)CARBAMOYL]-3-NAPHTHYL ACETATE
C19H14ClNO3 (339.06621640000003)
ETHYL 5-HYDROXY-8-(2-METHOXYETHYL)-2-(METHYLTHIO)-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE
C14H17N3O5S (339.08888720000004)
3-CHLORO-5-[[(ETHOXYCARBONYL)AMINO]SULFONYL]-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID, ETHYL ESTER
METHYL 4-CHLORO-2-(N-METHYL-N-PHENYLSULFAMOYL)BENZOATE
C15H14ClNO4S (339.03320340000005)
1-[4-[(3,4-dichlorophenyl)methoxy]-3-nitrophenyl]ethanone
C15H11Cl2NO4 (339.00651060000007)
N-(4-(4,6-Dichloropyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide
C14H11Cl2N3OS (338.99998560000006)
N-benzyl-1-[2-(bromomethyl)-1,3-dioxolan-2-yl]cyclopropane-1-carboxamide
2-Bromo-N-(2,4-dimethylphenyl)benzenesulfonamide
C14H14BrNO2S (338.99285640000005)
5-((4-(THIOPHEN-2-YL)QUINAZOLIN-6-YL)METHYLENE)THIAZOLIDINE-2,4-DIONE
1-(ISOCYANO(TOSYL)METHYL)-3-(TRIFLUOROMETHYL)BENZENE
(4-Bromo-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid
C13H15BBrNO4 (339.02774400000004)
Pumosetrag Hydrochloride
C15H18ClN3O2S (339.08081980000003)
Pumosetrag Hydrochloride (MKC-733; DDP-733) is an orally available 5-HT3 partial agonist developed for the treatment of irritable bowel syndrome and gastroesophageal reflux disease.
3-Bromo-5-(1-(2,2-diethoxyethyl)-1H-imidazol-2-yl)pyridine
tert-Butyl (3-bromo-5-(trifluoromethyl)phenyl)carbamate
C12H13BrF3NO2 (339.00816940000004)
2-(3-Hydroxyquinolin-2-yl)-cyclopentabnaphthalene-1,3-dione
4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride
C17H16Cl3N (339.03482660000003)
ETHYL4-CHLORO-6-METHOXY-7-(2-METHOXYETHOXY)QUINOLINE-3-CARBOXYLATE
C16H18ClNO5 (339.08734480000004)
5-Chloro-2-[[(4-methylphenyl)sulfonyl]amino]benzoic acid methyl ester
C15H14ClNO4S (339.03320340000005)
5-Bromo-N-Boc-indol-2-boronic acid
C13H15BBrNO4 (339.02774400000004)
7-OXO-3-PHENYL-2-(TRIFLUOROMETHYL)-4,7-DIHYDROTHIENO[3,2-B]PYRIDINE-6-CARBOXYLIC ACID
C15H8F3NO3S (339.0176974000001)
2-Methyl-2-propanyl (3S)-3-(4-bromophenyl)-1-piperidinecarboxylate
1-[(8-chloro-1-naphthyl)sulfonyl]proline
C15H14ClNO4S (339.03320340000005)
4-CARBOXY-7-CHLORO-2-(ETHOXYCARBONYL)INDOLE-3-PROPANOIC ACID
ethyl 6-broMo-5-hydroxy-1-Methyl-2-(2-oxoethyl)-1H-indole-3-carboxylate
C14H14BrNO4 (339.01061440000007)
N-Phenethyl 2-bromobenzenesulphonamide
C14H14BrNO2S (338.99285640000005)
DIETHYL 2-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]MALONATE
C13H13ClF3NO4 (339.04851640000004)
N-(5-iminobenzo[a]phenoxazin-9-yl)acetamide,hydrochloride
C18H14ClN3O2 (339.07744940000003)
1-(4-TRIFLUOROMETHYLPHENYL)-1-TOSYL]METHYLISOCYANIDE
2-Bromo-N-(2,3-dimethylphenyl)benzenesulfonamide
C14H14BrNO2S (338.99285640000005)
(6-Bromo-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid
C13H15BBrNO4 (339.02774400000004)
N-Benzyl-3-bromo-4-methylbenzenesulfonamide
C14H14BrNO2S (338.99285640000005)
Iofetamine hydrochloride I-123
V - Various > V09 - Diagnostic radiopharmaceuticals > V09A - Central nervous system > V09AB - Iodine (123i) compounds D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D019275 - Radiopharmaceuticals C1446 - Radiopharmaceutical Compound
2-[[(E)-3-(furan-2-yl)prop-2-enoyl]amino]-4-phenylthiophene-3-carboxylic acid
C18H13NO4S (339.05652580000003)
3-[5-(2-furanyl)-1H-pyrazol-3-yl]-4-(2-methoxyphenyl)-1H-1,2,4-triazole-5-thione
C16H13N5O2S (339.07899180000004)
Pacific Blue succinimidyl ester
An N-hydroxysuccinimide ester derived from 6,8-difluoro-7-hydroxycoumarin-3-carboxylic acid (pacific blue). A fluorescent dye of excitation wavelength 403 nm and emission wavelength 455 nm.
4-[5-(carboxymethyl)-4-phenyl-1,3-thiazol-2-yl]benzoic Acid
C18H13NO4S (339.05652580000003)
4-Methyl-6-(2,2,3,3,4,4,5,5-octafluoropentoxy)pyrimidin-2-amine
2-[4-[(4-Fluorophenyl)sulfonyl-methylamino]phenoxy]acetic acid
2-(2-fluorophenyl)-N-[4-(pyridin-2-yl)-1,3-thiazol-2-yl]cyclopropane-1-carboxamide
C18H14FN3OS (339.08415660000003)
4-[(5-chlorothiophen-2-yl)methyl]-N-[(furan-2-yl)methyl]piperazine-1-carboxamide
C15H18ClN3O2S (339.08081980000003)
2-Chloro-4-fluoro-N-{[(E)-2-phenylethenyl]sulfonyl}benzamide
versicolorin B(1-)
A phenolate anion obtained by deprotonation of the 8-hydroxy group of versicolorin B. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole
C9H14N3O9P (339.04676440000003)
A 1-(phosphoribosyl)imidazole having the phospho group at the 5-position and a carboxyamino group at the 5-position on the imidazole ring.
5-Hydroxycytidine 5-(Dihydrogen Phosphate)
C9H14N3O9P (339.04676440000003)
2-Deoxy-3-O-Sulfo-2-(Sulfoamino)-Alpha-D-Glucopyranose
[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(phosphonooxymethyl)oxan-2-yl] dihydrogen phosphate
C6H15NO11P2 (339.01203399999997)
2-(4,5-dihydrothiazol-2-ylthio)-N-(6-methoxy-1,3-benzothiazol-2-yl)acetamide
C13H13N3O2S3 (339.01698780000004)
3,4-dichloro-N-[(1-methyl-4-pyrazolyl)methyl]-1-benzothiophene-2-carboxamide
C14H11Cl2N3OS (338.99998560000006)
N-{[2-(2,4-dichlorophenoxy)acetyl]oxy}pyridine-2-carboximidamide
N-[4-chloro-3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]furan-2-carboxamide
1-[3-(Dimethylsulfamoyl)phenyl]-3-(2-furanylmethyl)thiourea
C14H17N3O3S2 (339.07112920000003)
1,3-Dimethyl-6-(4-morpholinylsulfonyl)quinazoline-2,4-dione
C14H17N3O5S (339.08888720000004)
N-[anilino(oxo)methyl]-2-methoxy-4-(trifluoromethyl)-3-pyridinecarboxamide
C15H12F3N3O3 (339.08307179999997)
4-chloro-3-ethoxy-N-(4-ethylphenyl)benzenesulfonamide
3-(3-bromo-4-methoxyphenyl)-N,N-diisopropylacrylamide
Methyl 5-(4-fluorophenyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-3-carboxylate
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-oxolanecarboxamide
3,4-dimethoxy-N-[3-(methylthio)phenyl]benzenesulfonamide
1-methyl-2-oxo-N-(2-pyridinyl)-6-benzo[cd]indolesulfonamide
C17H13N3O3S (339.0677588000001)
2-Thiophen-2-yl-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester
C18H13NO4S (339.05652580000003)
1-(3-Pyridinylmethyl)-3-[2-(trifluoromethyl)-1,3-benzodioxol-2-yl]urea
C15H12F3N3O3 (339.08307179999997)
2-methyl-N-(6-nitro-1,3-benzothiazol-2-yl)-3-phenylacrylamide
C17H13N3O3S (339.0677588000001)
N-(4,5-dihydrothiazol-2-yl)-2-thiophen-2-yl-4-quinolinecarboxamide
5-[(2-Chlorophenyl)methylamino]-2-(4-methoxyphenyl)-4-oxazolecarbonitrile
C18H14ClN3O2 (339.07744940000003)
3-(1-Benzotriazolylmethyl)-6-thiophen-2-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
N-[5-(2-methoxyethylthio)-1,3,4-thiadiazol-2-yl]-1,3-benzodioxole-5-carboxamide
[(2R,3S,4R,5R)-5-(4-amino-5-fluoro-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate
C9H11FN3O8P-2 (339.02677880000005)
N-[(E)-(2-Bromophenyl)methylideneamino]-4-methylquinolin-2-amine
C17H14BrN3 (339.03710240000004)
(E)-1,1,1-trifluoro-4-hydroxy-3-[(4-methylphenyl)iminomethyl]-4-thiophen-2-ylbut-3-en-2-one
Carboxyaminoimidazole ribotide
C9H14N3O9P (339.04676440000003)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
5-Phosphoribosyl-4-carboxy-5-aminoimidazole
C9H14N3O9P (339.04676440000003)
D007004 - Hypoglycemic Agents
5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid
C9H14N3O9P (339.04676440000003)
VU0238441
VU0238441 is a pan muscarinic acetylcholine receptor (mAChR) positive allosteric modulator (PAM) with EC50s of 3.2 μM, 2.8 μM, 2.2 μM, 2.1 μM, >10 μM for M1, M2, M3, M5 and M4, respectively[1][2].
(4e,8ar)-7-bromo-1,8a-dihydroxy-4-[(2-imino-1,3-dihydroimidazol-4-yl)methylidene]-3h-pyrrolo[1,2-a]pyrazin-6-one
C11H10BrN5O3 (338.99669700000004)